Zhangjiagang Huatian Pharmaceutical Co., Ltd., established on 2003-01-13, Business scope includes sterile raw materials,API,medicine,Manufacturing of medical devices,processing,Sell ​​self-produced products(Operate only after obtaining a license);Pharmaceutical Intermediates(Excluding hazardous chemicals)manufacturing,processing,Sell ​​self-produced products;food,Manufacture of food additives,processing,Sell ​​self-produced products(Operate only after obtaining a license);medicine,medical instruments,Pharmaceutical Intermediates,food,Technical consultation on food additives,Technical Services,technology development,technology transfer;Manage the export business of the company's self-produced products and technologies and the machinery and equipment required by the company,spare parts,Import and export business of raw and auxiliary materials and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:road freight transport(Does not contain dangerous goods)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Beijing Huajin Pharmaceutical Co., Ltd., a subsidiary of Grand Pharmaceutical Group Ltd., is a Chinese company that manufactures and sells injection and frozen-dried powder-injection products.

Established in 1945, Amorepacific is Korea’s No.1 beauty company and a blue-chip corporation. Amorepacific owns nearly 30 well-known brands and has been developing rapidly worldwide. Amorepacific pays great attention to product research and development through research centers located in Korea, France, Japan and Shanghai, to develop premium and high quality skincare and cosmetics products. The Group chose Hong Kong as a strategic bridgehead for the expansion of its presence across the Greater China region and the rest of the world. Two flagship brands - LANEIGE and Sulwhasoo, were introduced in Hong Kong in 2002 and 2004 respectively. The eponymous luxury brand – AMOREPACIFIC, was introduced in Hong Kong in 2014. In 2015, ETUDE HOUSE, a playful cosmetics brand, made its debut in the territory. In 2018, the Company set foot in the personal care product market, introducing the Group’s legendary hair care brand ‘Ryo’ into Hong Kong.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Genomatica develops biobased process technologies that enable a better way to produce widely-used chemicals, from alternative feedstocks, with better economics, sustainability, and performance. Genomatica has earned widespread acclaim for its technology; has commercialized processes for the chemical butanediol (for biodegradable plastics and apparel) and for butylene glycol (cosmetics and personal care), and is working on bio-nylon. Awards include the Kirkpatrick Award, for “the most noteworthy chemical engineering technology commercialized in the world” and the ICIS Innovation Award for its Brontide(TM) butylene glycol.

Proya Cosmetics Co., Ltd. engages in the research, development, production and sale of cosmetic products. The firm's brands include Proya, Timage, Off&Relax, Hapsode, Correctors, Uzro, and Hanya. Ther company offers face wash, hydra relaxing luminizer massage cream, whitening sun lock cream and aqua secret refreshing cream. It operates deprtment stores, cosmetic boutiques, supermarket chains, and electronic business platforms. Proya Cosmetics was founded on May 24, 2006 and is headquartered in Hangzhou, China.

Hainan General & Kangli Pharmaceutical Co., Ltd. is a company headquartered in China ultimately controlled by the Government of China. The firm manufactures and wholesales pharmaceutical products.

Metabasis is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs by applying its proprietary technologies, scientific expertise and unique capabilities for targeting the liver and liver pathways. The Company has established a broad pipeline of product candidates and advanced research programs targeting large markets with significant unmet needs. Metabasis' product pipeline represents candidates indicated for the treatment of metabolic diseases such as hyperlipidemia and diabetes, among others. Additionally, our pipeline includes drug candidates for the treatment of liver diseases such as hepatitis and primary liver cancer which the company plans to license to companies focused on these areas. All of our product candidates were developed internally using proprietary technologies including our NuMimetic and HepDirect technologies.

BIOMEDICA FOSCAMA INDUSTRIA Chimico-Farmaceutica SpA operates pharmaceutical and drug stores. Its products include Esafosfina, TAD, Ursolac, and CV & CNS drugs. The company provides products in the areas of metabolism and parenteral nutrition. BIOMEDICA FOSCAMA INDUSTRIA Chimico-Farmaceutica was founded in 1947 and is headquartered in Ferentino, Italy

Guangdong Hongyuan Group Pharmaceutical Co., Ltd., established on 1994-12-20, Business scope includes manufacturing,Sales:large volume injection,Freeze-dried powder injection,tablet,hard capsule,Granules,API(Sodium foscarnet,Tanshinone ⅡASodium sulfonate,minodronic acid),Powder;property lease;car park service;Acquisition of agricultural and sideline products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Cisen Pharmaceutical Ltd. engages in the manufacturing of comprehensive chemical and pharmaceutical products. It sells liver, antitumor & auxiliary, nutrition, cardiovascular, antibiotics, sedation anesthesia snooze, digestive system, cough & asthma class, immunomodulator, basic infusion, therapeutic infusion, polypropylene ampoules disease drugs. The company key products include Dirithromycin Enteric-coated Capsules, Voglibose Capsules, Cycloclenbuterol Hydrochloride Tablets, Pantoprazole Sodium Enteric-Coated Tablets, Dexmedetomidine Hydrochloride, Sodium Chloride, Iohexol, Oxaliplatin & Mannitol Injection, Adefovir Dipivoxil Tablets, Glycerol Fructose & Sodium Chloride Injection and other related drugs. Cisen Pharmaceutical was founded on November 6, 1998 and is headquartered in Jining, China.

Guangdong Huamei Zhongyuan Biotechnology Co., Ltd., established on 2013-07-25, Business scope includes general items:Biochemical product technology research and development;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products);Medical Research and Experimental Development;Machinery and Equipment Leasing;Cosmetics Retail;Cosmetics Wholesale;Development of Human Gene Diagnosis and Therapy Technology;Sales of Class I Medical Devices;Experimental analysis instrument sales;Drug testing equipment sales;Sales of formula food for special medical purposes;Healthy food(prepackaged)Sales;food sales(Only sell prepackaged food);Food Internet Sales(Only sell prepackaged food);internet sales(Except for products that require a license for sale);Health Consulting Services(Does not include medical services);Environmental Protection Monitoring.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Inspection and testing service;Forensic identification service;medical service;Labor dispatch service;pharmaceutical production;Production of formula food for special medical purpose.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shanghai Tianlong Pharmaceutical Co., Ltd., established on 1993-11-08, Business scope includes licensed projects:pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Non-residential real estate leases,car park service,property management.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Unitika Ltd. engages in the polymer and functional materials business. It operates through the following business segments: Polymer, Functional Material, Fiber, and Others. The Polymer segment manufactures and sells plastic film, resin, and non-woven cloth. The Functional Material segment handles the manufacture and sale of glass fibers. The Fiber segment deals with the manufacture and sale of various fibers such as thread, cotton, and knitted fibers. The Others segment includes environmental business, medical business, lifestyle and wellness, and real estate businesses. The company was founded on June 19, 1889 and is headquartered in Osaka, Japan.

Hainan Quanxing Pharmaceutical Co., Ltd., established on 2001-10-29, Business range includes tablet,Capsules,Granules,gel,ointment,cream(contain hormones),small volume injection(Contains antineoplastic drugs),dry suspension,Freeze-dried powder injection(Contains antineoplastic drugs),powder injection(Contains cephalosporins),suppositories,Pills,Second class psychotropic drug preparations,API production and sales,marine medicine,Nanyao,Development of pharmaceutical reagents,to develop,Medical Technology Consulting Services,Daily protective mask,Disposable medical mask,Medical Surgical Mask,Medical protective mask,medicalN95Face mask,children's masks,Melt blown cloth,Production and sales of non-woven products.(General operating items self-management,Licensed business projects are operated on the basis of relevant licenses or approval documents)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Shanghai Fosun Xingtai Pharmaceutical Technology Co., Ltd., established on 2006-08-16, The scope of business includes the research of medical technology in the field of biomedicine,to develop,transfer of own technology,Provide relevant technical consultation and technical services,Health food research and development,food circulation,Biological reagents for non-clinical diagnosis,Pharmaceutical Intermediates(In addition to drugs),Chemical raw materials and products(In addition to dangerous goods)promotion of,Engaged in the import and export of goods and technology,Business Management Consulting,hospital management. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Hainan MeilanShiKline Pharmaceutical Co., Ltd., established on 2002-01-24, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Non-residential real estate leases;property management(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)(General operating items self-management,Licensed business projects are operated on the basis of relevant licenses or approval documents)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Zhuhai Tongyuan Pharmaceutical Co., Ltd., established on 1990-05-11, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Disinfectant production(Free of Hazardous Chemicals);Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices;Disinfectant sales(Free of Hazardous Chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Merck (d.b.a. EMD Millipore in the U.S. and Canada) is a German chemical and pharmaceutical company. Merck, also known as “German Merck” and “Merck Darmstadt”, was founded in Darmstadt, Germany, in 1668, making it the world's oldest operating chemical and pharmaceutical company. The company was privately owned until going public in 1995. However, the Merck family still controls a majority (≈70%) of the company's shares. Following World War I, Merck lost possession of its foreign sites, including the Merck & Co. subsidiary in the United States. Merck & Co., which operates as Merck Sharp and Dohme (MSD) outside the U.S. and Canada, is now an independent company. Merck KGaA operates mainly in Europe, Africa, Asia, Oceania and Latin America. Since Merck & Co. holds the rights to the Merck name in the U.S. and Canada, the company operated under the umbrella brand EMD Chemicals in North America, and since 2010 as EMD Millipore (after the acquisition of Millipore Corporation), formed from the initials of Emanuel Merck, Darmstadt. Founded in 1668 in Darmstadt, Merck KGaA of Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The success of the export business to the United States led in 1887 to the establishment of an office in New York, which gave rise to their subsidiary [Merck & Co.](http://www.crunchbase.com/organization/merck-co-inc) four years later. Owing to World War I, Merck & Co. was expropriated in 1917. The two companies have been separate every since. Merck KGaA Subsidiaries: - [Merck Consumer Healthcare](http://www.crunchbase.com/organization/merck-consumer-healthcare) - [Merck Performance Materials](http://www.crunchbase.com/organization/merck-performance-materials)